Genmab will stop development of its experimental antibody therapy to treat cancer that was in late-stage trials, the Danish ...

The decision to discontinue further clinical development of Acasunlimab does not impact Genmab’s full‑year 2025 financial guidance, the company said. ・Genmab assumed sole responsibility for the ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

A new study reveals how a single cancer protein may simultaneously drive tumor survival and metabolic control, uncovering a hidden link between two core features of cancer. Scientists have uncovered a ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family linked to cancer development. The findings have been published in Nature ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.